Your browser doesn't support javascript.
loading
Protocol for phase I study of pembrolizumab in combination with Bacillus Calmette-Guérin for patients with high-risk non-muscle invasive bladder cancer.
Jamil, Marcus L; Deebajah, Mustafa; Sood, Akshay; Robinson, Kathy; Rao, Krishna; Sana, Sherjeel; Alanee, Shaheen.
Afiliação
  • Jamil ML; Henry Ford Hospital, Vattikuti Urology Institute Henry Ford Hospital, Detroit, Michigan, USA.
  • Deebajah M; Henry Ford Hospital, Vattikuti Urology Institute Henry Ford Hospital, Detroit, Michigan, USA.
  • Sood A; Henry Ford Hospital, Vattikuti Urology Institute, Detroit, Michigan, USA.
  • Robinson K; Southern Illinois University School of Medicine, Springfield, Illinois, USA.
  • Rao K; Southern Illinois University School of Medicine, Springfield, Illinois, USA.
  • Sana S; Southern Illinois University School of Medicine, Springfield, Illinois, USA.
  • Alanee S; Henry Ford Hospital, Vattikuti Urology Institute, Detroit, Michigan, USA.
BMJ Open ; 9(7): e028287, 2019 07 17.
Article em En | MEDLINE | ID: mdl-31320352
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Vacina BCG / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Vacina BCG / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article